Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy

被引:462
作者
Lohcharoenkal, Warangkana [1 ]
Wang, Liying [2 ]
Chen, Yi Charlie [3 ]
Rojanasakul, Yon [1 ,4 ]
机构
[1] W Virginia Univ, Dept Pharmaceut Sci, Morgantown, WV 26506 USA
[2] NIOSH, Pathol & Physiol Res Branch, Morgantown, WV 26505 USA
[3] Alderson Broaddus Coll, Nat Sci Div, Philippi, WV 26416 USA
[4] W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA
基金
美国国家科学基金会;
关键词
ALBUMIN-BOUND PACLITAXEL; IN-VITRO RELEASE; GELATIN NANOPARTICLES; BETA-LACTOGLOBULIN; GLIADIN NANOPARTICLES; CELLULAR UPTAKE; OPTIMIZATION; FORMULATION; FABRICATION; ANTITUMOR;
D O I
10.1155/2014/180549
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Nanoparticles have increasingly been used for a variety of applications, most notably for the delivery of therapeutic and diagnostic agents. A large number of nanoparticle drug delivery systems have been developed for cancer treatment and various materials have been explored as drug delivery agents to improve the therapeutic efficacy and safety of anticancer drugs. Natural biomolecules such as proteins are an attractive alternative to synthetic polymers which are commonly used in drug formulations because of their safety. In general, protein nanoparticles offer a number of advantages including biocompatibility and biodegradability. They can be prepared under mild conditions without the use of toxic chemicals or organic solvents. Moreover, due to their defined primary structure, protein-based nanoparticles offer various possibilities for surface modifications including covalent attachment of drugs and targeting ligands. In this paper, we review the most significant advancements in protein nanoparticle technology and their use in drug delivery arena. We then examine the various sources of protein materials that have been used successfully for the construction of protein nanoparticles as well as their methods of preparation. Finally, we discuss the applications of protein nanoparticles in cancer therapy.
引用
收藏
页数:12
相关论文
共 95 条
[1]   Formation and potential uses of milk proteins as nano delivery vehicles for nutraceuticals: A review [J].
Abd El-Salam, Mohamed H. ;
El-Shibiny, Safinaz .
INTERNATIONAL JOURNAL OF DAIRY TECHNOLOGY, 2012, 65 (01) :13-21
[2]  
Alexis Frank, 2010, Handb Exp Pharmacol, P55, DOI 10.1007/978-3-642-00477-3_2
[3]  
[Anonymous], 2008, GLOBOCAN DATABASE VE
[4]   Bioadhesive potential of gliadin nanoparticulate systems [J].
Arangoa, MA ;
Ponchel, G ;
Orecchioni, AM ;
Renedo, MJ ;
Duchêne, D ;
Irache, JM .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 11 (04) :333-341
[5]   Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs. Relationships between bioadhesion and pharmacokinetics [J].
Arangoa, MA ;
Campanero, MA ;
Renedo, MJ ;
Ponchel, G ;
Irache, JM .
PHARMACEUTICAL RESEARCH, 2001, 18 (11) :1521-1527
[6]   Biocompatible fluorescent zein nanoparticles for simultaneous bioimaging and drug delivery application [J].
Aswathy, Ravindran Girija ;
Sivakumar, Balasubramanian ;
Brahatheeswaran, Dhandayudhapani ;
Fukuda, Takahiro ;
Yoshida, Yasuhiko ;
Maekawa, Toru ;
Kumar, D. Sakthi .
Advances in Natural Sciences: Nanoscience and Nanotechnology, 2012, 3 (02)
[7]  
Azarmi S, 2006, J PHARM PHARM SCI, V9, P124
[8]  
Babaei Z., 2008, Int. J. Nanosci. Nanotechnol, V4, P23, DOI [10.3390/pharmaceutics12070604, DOI 10.3390/PHARMACEUTICS12070604]
[9]  
Bruce A., 2002, MOL BIOL CELL, P151
[10]   Food protein-based materials as nutraceutical delivery systems [J].
Chen, LY ;
Remondetto, GE ;
Subirade, M .
TRENDS IN FOOD SCIENCE & TECHNOLOGY, 2006, 17 (05) :272-283